Enveric Biosciences, Inc. — Investor Relations & Filings
Filings indexed
1,027
across all filing types
Latest filing
2026-05-29
Regulatory Filings
Country
US
United States of America
Listing
US
ENVB
Enveric Biosciences is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of neuropsychiatric disorders. The company focuses on conditions such as anxiety, depression, and addiction. Leveraging its proprietary discovery and development platform, The Psybrary™, Enveric has created a robust intellectual property portfolio of novel molecules for specific mental health indications. Its development pipeline includes candidates such as EB-003 for difficult-to-treat mental health disorders and the EVM301 series.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-29 | English | |
| 10-Q | 2026-05-15 | English | |
| 8-K | 2026-05-15 | English | |
| Regulatory Filings 2026 | 2026-05-04 | English | |
| 8-K | 2026-04-30 | English | |
| DEFA14A | 2026-04-30 | English |
Browse filings by year
31 years- 2026 28 filings
- 2025 73 filings
- 2024 62 filings
- 2023 78 filings
- 2022 54 filings
- 2021 92 filings
- 2020 58 filings
- 2019 35 filings
- 2018 97 filings
- 2017 91 filings
- 2016 57 filings
- 2015 46 filings
- 2014 15 filings
- 2013 12 filings
- 2012 10 filings
- 2011 5 filings
- 2010 10 filings
- 2009 41 filings
- 2008 11 filings
- 2007 22 filings
- 2006 17 filings
- 2005 19 filings
- 2004 11 filings
- 2003 10 filings
- 2002 11 filings
- 2001 8 filings
- 2000 11 filings
- 1999 7 filings
- 1998 16 filings
- 1997 8 filings
- 1996 12 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47893829 | 8-K | 2026-05-29 | English | ||
| 46353964 | 10-Q | 2026-05-15 | English | ||
| 46353922 | 8-K | 2026-05-15 | English | ||
| 46199472 | Regulatory Filings 2026 | 2026-05-04 | English | ||
| 46199471 | 8-K | 2026-04-30 | English | ||
| 46199478 | DEFA14A | 2026-04-30 | English | ||
| 46199504 | Regulatory Filings 2026 | 2026-04-30 | English | ||
| 38840524 | 424B3 - Enveric Biosciences, Inc. (0000890821) (Filer) | 2026-04-29 | English | ||
| 46199502 | S-3 | 2026-04-23 | English | ||
| 46199491 | 8-K | 2026-04-18 | English | ||
| 34522124 | ARS - Enveric Biosciences, Inc. (0000890821) (Filer) | 2026-04-14 | English | ||
| 46199509 | DEFA14A | 2026-04-14 | English | ||
| 34522134 | DEF 14A - Enveric Biosciences, Inc. (0000890821) (Filer) | 2026-04-14 | English | ||
| 46199510 | PRE 14A | 2026-04-03 | English | ||
| 33066423 | 10-K - Enveric Biosciences, Inc. (0000890821) (Filer) | 2026-03-27 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AIM ImmunoTech Inc.
Immuno-pharma company developing therapeutics for oncology,…
|
AIM | US | Professional, scientific and te… |
|
Ainos, Inc.
Develops AI-driven diagnostics, immune therapeutics, and te…
|
AIMD | US | Professional, scientific and te… |
|
Akela Pharma Inc.
Integrated drug developer focused on pain and inhalation, p…
|
— | CA | Professional, scientific and te… |
|
Akero Therapeutics, Inc.
Clinical-stage company developing treatments for serious me…
|
AKRO | US | Professional, scientific and te… |
|
Aladdin Healthcare Technologies SE
Develops AI-powered tools for drug discovery and diagnostic…
|
NMI | DE | Professional, scientific and te… |
|
Alamar Biosciences, Inc.
Powering precision proteomics for earliest disease detectio…
|
ALMR | US | Professional, scientific and te… |
|
Alaunos Therapeutics, Inc.
Clinical-stage immuno-oncology company developing TCR-T cel…
|
TCRT | US | Professional, scientific and te… |
|
ALGORAE PHARMACEUTICALS LIMITED
Biopharmaceutical firm using AI to develop neurodegenerativ…
|
1AI | AU | Professional, scientific and te… |
|
Aligos Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing thera…
|
ALGS | US | Professional, scientific and te… |
|
Allelix Biopharmaceuticals Inc.
Biopharmaceutical R&D focused on protein-based drugs and ne…
|
ALX | CA | Professional, scientific and te… |
Enveric Biosciences, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35460/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35460 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35460 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35460 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35460}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Enveric Biosciences, Inc. (id: 35460)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.